Presumed topiramate-induced maculopathy

Epilepsy and Behavior

Volumn 14, Issue 3, 2009, Pages 556-559

  Beyenburg, Stefan ^a   Weyland, Christophe ^b   Reuber, Markus ^c  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b Cabinet d'Ophtalmologie   (Luxembourg)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Antiepileptic drugs; Epilepsy; Maculopathy; Ocular side effects; Retina; Topiramate; Toxicity; Vision; Visual field

Indexed keywords

ATENOLOL; CYCLOSPORIN A; ETIRACETAM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TOPIRAMATE; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MONOTHERAPY; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; RETINA MACULOPATHY; SYMPTOMATIC EPILEPSY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

ADULT; ANTICONVULSANTS; CEREBRAL ANGIOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; FEMALE; FRUCTOSE; HUMANS; MACULAR DEGENERATION; MAGNETIC RESONANCE IMAGING; VISION TESTS;

EID: 63049120383     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.12.015     Document Type: Article

References (14)

1. Lyseng-Williamson K.A., and Yang L.P. Topiramate: a review of its use in the treatment of epilepsy. Drugs 67 (2007) 2231-2256
2. Santaella R.M., and Fraunfelder F.W. Ocular adverse effects associated with systemic medications: recognition and management. Drugs 67 (2007) 75-93
3. Panday V.A., and Rhee D.J. Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update 8 (2007) 271-276
4. Chatterjee S., Mandal A., Ganguly G.K., and Bose S. Topiramate induced visual field defects: a case series. Drug Saf 29 (2006) P911 [abstract]
5. Vaphiades M.S., and Mason J. Foggy visual field defect. Surv Ophthalmol 49 (2004) 266-267
6. Asensio-Sánchez V.M., Torreblanca-Agüera B., Martínez-Calvo S., Calvo M.J., and Rodríguez R. Severe ocular side effects with Topamax. Arch Soc Esp Oftalmol 81 (2006) 345-348
7. Tsui I., Casper D., Chou C.L., and Tsang S.H. Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathy. Doc Ophthalmol 116 (2008) 57-60
8. Li J., Tripathi R.C., and Tripathi B.J. Drug-induced ocular disorders. Drug Saf 31 (2008) 127-141
9. Rohrschneider K., Bultmann S., and Springer C. Use of fundus perimetry (microperimetry) to quantify macular sensitivity. Prog Retin Eye Res 27 (2008) 536-548
10. Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol 19 (2008) 255-262
11. Chung H., Kim K.H., Kim J.G., Lee S.Y., and Yoon Y.H. Retinal complications in patients with solid organ or bone marrow transplantations. Transplantation 83 (2007) 694-699
12. López-Jiménez J., Sánchez A., Fernández C.S., Gutiérrez C., and Herrera P. Odriozola J Cyclosporine-induced retinal toxic blindness. Bone Marrow Transplant 20 (1997) 243-245
13. Tilz C., Wang-Tilz Y., Jünemann A., Stefan H., and Michelson G. Visual field defect during therapy with valproic-acid. Eur J Neurol 14 (2007) 929-932
14. Kjellström S., Bruun A., Isaksson B., Eriksson T., Andréasson S., and Ponjavic V. Retinal function and histopathology in rabbits treated with topiramate. Doc Ophthamol 113 (2006) 179-186